Cargando...

Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles

Background. Recombinant DNA and modified vaccinia virus Ankara (rMVA) vaccines represent a promising approach to an HIV/AIDS vaccine. This Phase 1 clinical trial compared the safety and immunogenicity of a rMVA vaccine administered with and without DNA vaccine priming Methods. GeoVax pGA2/JS7 DNA (D...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Goepfert, Paul A., Elizaga, Marnie L., Sato, Alicia, Qin, Li, Cardinali, Massimo, Hay, Christine M., Hural, John, DeRosa, Stephen C., DeFawe, Olivier D., Tomaras, Georgia D., Montefiori, David C., Xu, Yongxian, Lai, Lilin, Kalams, Spyros A., Baden, Lindsey R., Frey, Sharon E., Blattner, William A., Wyatt, Linda S., Moss, Bernard, Robinson, Harriet L.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2011
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3072720/
https://ncbi.nlm.nih.gov/pubmed/21282192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiq105
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!